Advancing clinical pharmacology, translational science, and therapeutics for the benefit of patients and society.
ASCPT's influence and leadership drives the advancement of translational science, building on a foundation of clinical pharmacology and therapeutics.
Clinical pharmacology and translational science drive the innovation, development, and use of therapeutics to enhance patient care.
The continuum of clinical pharmacology and translational science stimulates collaborations between academia, regulators, and industry professionals in the discovery, development, and regulation of safe and effective therapies.
The unique strength of ASCPT lies in its multidisciplinary nature and its ability to be a catalyst for emerging clinical pharmacology and translational science.
ASCPT demonstrates the highest standards of ethics and integrity and fosters these values in its leadership, members, staff, and contributors.
ASCPT is committed to inclusive participation and diversity of perspective.
ENHANCE CAREER GROWTH.
ASCPT will attract and serve a diverse and global membership by providing opportunities, skills training, and networks to empower ASCPT members to thrive in every stage of their career.
STIMULATE SCIENTIFIC ADVANCEMENTS.
ASCPT will prepare clinical pharmacologists and translational scientists for the future by promoting the development and application of new technologies and methodologies and encouraging multidisciplinary collaboration.
EXPAND PATIENT-FOCUSED ENGAGEMENT.
ASCPT will expand outreach to patient groups and health professionals to increase the exchange of information regarding patients’ needs and the benefit of clinical pharmacology and translational science in the development of new therapies.
DIVERSIFY LEARNING EXPERIENCES.
ASCPT will provide educational experiences and resources that are innovative, relevant, and accessible.
PROVIDE EXEMPLARY VALUE.
ASCPT will strengthen operational excellence by providing products and services that are sustainable, inclusive, and responsive to the needs of ASCPT members and stakeholders.
Kellie Schoolar Reynolds, PharmD, Chair
Susan M. Abdel-Rahman, PharmD
Aline Barth, PhD
Kristin Bigos, PhD
Kim L. R. Brouwer, PharmD, PhD
Donald Heald, PhD
Anne Heatherington, PhD
Vijay Ivaturi, PhD
Julie Johnson, PharmD
Steven E. Kern, PhD
France Mentré, MD, PhD
David Y. Mitchell, PhD
Richard Peck, MD
David Strauss, MD, PhD
